Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Hookipa Pharma Inc
(NQ:
HOOK
)
0.7410
-0.0190 (-2.50%)
Streaming Delayed Price
Updated: 3:15 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
346,980
Open
0.7500
Bid (Size)
0.7410 (2)
Ask (Size)
0.7489 (2)
Prev. Close
0.7600
Today's Range
0.7312 - 0.7999
52wk Range
0.4100 - 1.779
Shares Outstanding
21,588,756
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
April 15, 2024
Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + GemOx vs. Rituxan + GemOx.
Via
Benzinga
Performance
YTD
-10.72%
-10.72%
1 Month
+0.78%
+0.78%
3 Month
+11.28%
+11.28%
6 Month
+52.78%
+52.78%
1 Year
+0.75%
+0.75%
More News
Read More
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
April 10, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma: Q4 Earnings Insights
March 22, 2024
Via
Benzinga
HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Beats Revenue for Q4 2023
March 22, 2024
Via
InvestorPlace
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
March 22, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
March 06, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
February 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 01, 2024
Via
Benzinga
Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
Via
Benzinga
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
January 29, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
AbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades'
January 18, 2024
Via
Benzinga
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
January 16, 2024
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
December 25, 2023
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 22, 2023
Via
Benzinga
Nasdaq Gains 100 Points; CarMax Earnings Top Views
December 21, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 21, 2023
Via
Benzinga
Crude Oil Moves Lower; Micron Issues Strong Forecast
December 21, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?
December 21, 2023
Via
Benzinga
Dow Jumps 250 Points; US Weekly Jobless Claims Edge Higher
December 21, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Polished.com (POL) Stock Down 38% Today?
December 21, 2023
Via
InvestorPlace
Why Is Brenmiller Energy (BNRG) Stock Up Today?
December 21, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.